UPDATED Aug 30, 2025
Discover U.S. Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the NYSE and NASDAQ and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
RVTY | US$90.11 | -4.3% | -26.5% | US$10.5b | US$116.81 | PE37.5x | E24.3% | 0.3% | ||
STVN | US$23.01 | 1.7% | 5.2% | US$6.3b | US$28.63 | PE39.9x | E19.2% | 0.3% | ||
VERU | US$3.25 | -9.7% | -60.3% | US$47.6m | US$19.75 | PS2.8x | E14.3% | 0% | ||
INDV | US$24.28 | -0.2% | 94.2% | US$3.0b | US$29.17 | PE57.2x | E47.6% | 0% | ||
PRPH | US$0.34 | 2.8% | -87.4% | US$14.0m | US$13.80 | PS2.5x | E149.5% | 0% | ||
INVA | US$20.43 | 1.4% | 5.4% | US$1.3b | US$41.00 | PE33.3x | E32.2% | 0% | ||
AZTA | US$30.54 | -3.2% | -38.3% | US$1.4b | US$33.00 | PS2.1x | E102.2% | 0% | ||
AMRX | US$9.56 | -0.3% | 10.4% | US$3.0b | US$12.00 | PE889.7x | E80.6% | 0% | ||
IQV | US$190.81 | -0.2% | -24.1% | US$32.4b | US$215.05 | PE26.2x | E13.2% | 0% | ||
TEVA | US$18.38 | -0.4% | -2.6% | US$21.1b | US$23.56 | PS1.3x | E31.1% | 0% |